| MDDAX | VIVAX | MDDAX / VIVAX | |
| Total Expense Ratio | 1.14 | 0.17 | 671% |
| Annual Report Gross Expense Ratio | 1.14 | 0.17 | 671% |
| Fund Existence | 21 years | 33 years | - |
| Gain YTD | -11.620 | 11.753 | -99% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 457M | 208B | 0% |
| Annual Yield % from dividends | 1.34 | 1.93 | 69% |
| Returns for 1 year | -23.87 | 4.76 | -502% |
| Returns for 3 years | -31.70 | 29.79 | -106% |
| Returns for 5 years | -19.18 | 61.14 | -31% |
| Returns for 10 years | -33.19 | 127.21 | -26% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LMUB | 50.40 | 0.13 | +0.26% |
| iShares Long-Term National Muni Bd ETF | |||
| FJUL | 55.45 | 0.09 | +0.16% |
| FT Vest US Equity Buffer ETF Jul | |||
| LCF | 41.88 | N/A | N/A |
| Touchstone US Large Cap Focused ETF | |||
| LFAI | 157.19 | N/A | N/A |
| LifeX 2050 Longevity Income ETF | |||
| PBE | 81.50 | -0.01 | -0.01% |
| Invesco Biotechnology & Genome ETF | |||